TMO
50
-4
MAC
65
-3
IBM
62
-3
COF
67
2
AMP
67
-5
ALLE
41
-9
AMAT
50
-2
CA
27
9
OXY
33
-4
PCG
67
-2
NSC
59
-3
NOV
47
-6
PGR
55
-3
HD
31
-3
MCHP
45
-4
FCX
72
-2
SNA
50
-3
FLS
50
-5
SIG
52
5
AZO
43
-5
TMO
50
-4
MAC
65
-3
IBM
62
-3
COF
67
2
AMP
67
-5
ALLE
41
-9
AMAT
50
-2
CA
27
9
OXY
33
-4
PCG
67
-2
NSC
59
-3
NOV
47
-6
PGR
55
-3
HD
31
-3
MCHP
45
-4
FCX
72
-2
SNA
50
-3
FLS
50
-5
SIG
52
5
AZO
43
-5
Financhill
Back

First Trust NASDAQ Technology Dividend Index Fund Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Sell
32

TDIV
First Trust NASDAQ Technology Dividend Index Fund

Last Price:
$94.88
Seasonality Move:
1.23%
Sell
34

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.71
Seasonality Move:
-18.07%
Sell
32
First Trust NASDAQ Technology Dividend Index Fund (TDIV) is a Sell

Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?

  • The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $96.69. The Score for TDIV is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • TDIV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.96. The Score for INKT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TDIV Stock Price Chart

What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?

  • The First Trust NASDAQ Technology Dividend Index Fund share price today is $96.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TDIV is experiencing slight buying pressure.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight selling pressure.

TDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 44.67 Sell
Chaikin Money Flow: 28179 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 47.65 Sell
Chaikin Money Flow: -11714 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.88 - 12.8) Buy
Bollinger Bands (100): (12.31 - 15.41) Sell

TDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 99.46 Sell
20-day SMA: 97.27 Sell
50-day SMA: 98.43 Sell
200-day SMA: 88.31 Buy
8-day EMA: 98.39 Sell
20-day EMA: 98.17 Sell
50-day EMA: 95.95 Buy
200-day EMA: 60.62 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.29 Sell
20-day SMA: 11.54 Buy
50-day SMA: 12.98 Sell
200-day SMA: 11.84 Buy
8-day EMA: 12.15 Sell
20-day EMA: 12.09 Sell
50-day EMA: 12.72 Sell
200-day EMA: 12.23 Sell

First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

First Trust NASDAQ Technology Dividend Index Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):